logo
New Report: 72 Million Adults in the US Lack Dental Insurance, Nearly Three Times the Number Without Health Insurance

New Report: 72 Million Adults in the US Lack Dental Insurance, Nearly Three Times the Number Without Health Insurance

Business Wire21-05-2025

BOSTON--(BUSINESS WIRE)-- A new report from CareQuest Institute for Oral Health ® reveals that 27% of US adults — an estimated 72 million people — do not have dental insurance, nearly three times the number of adults who lack health insurance (9.5%, or 26 million). The findings, from the latest State of Oral Health Equity in America (SOHEA) survey, underscore a persistent and troubling gap in access to dental care.
Lack of dental insurance puts adults at risk for delayed treatment and worsening oral health, which is closely tied to broader health problems, including diabetes, heart disease, and even dementia.
'These findings reinforce the fact that oral health care is too expensive and out of reach for too many families in America,' said Melissa Burroughs, Senior Director of Public Policy at CareQuest Institute. 'Gaps in dental insurance force families to make impossible tradeoffs between things like putting food on the table and getting the care they need — any cuts to the Medicaid program would only make this problem worse. It's time for policy solutions that address our nation's oral health, starting by preserving Medicaid adult dental coverage.'
The report, Out of Pocket: A Snapshot of Adults' Dental and Medical Care Coverage, also finds that:
Adults with lower incomes and education levels are more likely to lack dental insurance. 40% of adults without a high school diploma and 38% of those earning under $30,000 annually are uninsured for dental care.
One-third of adults with Medicare or Medicaid lack dental coverage. Traditional Medicare does not include dental services, and Medicaid adult dental coverage varies widely by state.
More than 80% of adults without health insurance also lack dental insurance.
Nearly one in four adults with dental insurance gained it in the last year, either by changing from a previous insurance plan to a new plan or by enrolling in an insurance plan after being uninsured.
Among adults currently without dental insurance, 12% lost coverage in the past year, disproportionately affecting younger adults and Asian/Pacific Islander, Black, and Hispanic adults.
Despite growing recognition that oral health is essential to overall health, significant policy gaps remain. Medicare does not guarantee dental coverage, Medicaid coverage for adults is optional and inconsistent across states, and marketplace dental plans often lack affordability and accessibility, with no subsidies available.
The SOHEA survey is the largest nationally representative survey focused exclusively on oral health attitudes, behaviors, and experiences among adults. Conducted from March to May 2024 by the National Opinion Research Center (NORC) at the University of Chicago, the study reflects the voices of more than 9,000 adults nationwide.
The full report is available here.
About CareQuest Institute for Oral Health ®
CareQuest Institute for Oral Health ® is a national nonprofit championing a more equitable future where every person can reach their full potential through excellent health. We do this through our work in philanthropy, analytics and data insights, health transformation, policy and advocacy, and education, as well as our leadership in dental benefits and innovation advancements. We collaborate with thought leaders, health care providers, patients, and local, state, and federal stakeholders to accelerate oral health care transformation and create a system designed for everyone. To learn more, visit carequest.org and follow us on Twitter/X, LinkedIn, Facebook, and Instagram.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Backing the Future of Global Biotech: Reynold Lemkins' Strategy Across Borders and Stages
Backing the Future of Global Biotech: Reynold Lemkins' Strategy Across Borders and Stages

Yahoo

time41 minutes ago

  • Yahoo

Backing the Future of Global Biotech: Reynold Lemkins' Strategy Across Borders and Stages

HONG KONG, June 10, 2025--(BUSINESS WIRE)--Reynold Lemkins Group, an international investment firm focused on value-driven cross-border capital deployment, announced the continued advancement of its strategic focus in late-stage healthcare, AI-powered therapeutics, and Asia-centered biotech commercialization. As part of this strategy, Reynold Lemkins recently participated in the IPO of VISEN Pharmaceuticals on the Hong Kong Stock Exchange (HKEX: 02561). VISEN, a biopharmaceutical company specializing in long-acting growth hormone therapies, attracted strong institutional demand and represents the kind of regulatory-validated, commercially scalable business the firm targets. Reynold Lemkins invested alongside globally recognized healthcare investors including HongShan Capital Group (previously Sequoia China), Sofinnova, Vivo Capital, OrbiMed, and WuXi Biologics (HKEX: 2269), reinforcing its commitment to cross-border innovation and long-term capital alignment. This investment underscores Reynold Lemkins' broader strategy of supporting science-driven, late-stage companies with scalable market potential—particularly those operating at the convergence of AI, therapeutics, and Asia-Pacific commercialization. "Our approach focuses on more than capital—we provide strategic insight and cross-border connectivity to help companies scale," said Kris Haoran Liu, President and Chief Investment Officer at Reynold Lemkins Group. "Biotech firms entering public markets need partners who understand both the science and the structure of global growth." With Asia playing an increasingly pivotal role in global healthcare, Reynold Lemkins sees a growing need for capital strategies that link scientific innovation with scalable regional execution. At the same time, the firm closely tracks trends in the U.S. and other mature markets, where biotech companies are navigating longer paths to liquidity and require strategic partners with global reach. Reynold Lemkins positions itself at this intersection—bridging East and West, public and private markets—to support companies shaping the next era of patient-centered care. To learn more, visit follow us on LinkedIn, or explore our insights on Medium. View source version on Contacts Reynold Lemkins Groupreynoldlemkins@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

ZoomCare Opens New Clinic in Happy Valley
ZoomCare Opens New Clinic in Happy Valley

Yahoo

time43 minutes ago

  • Yahoo

ZoomCare Opens New Clinic in Happy Valley

The company will host an Open House for the community on Jun. 13 PORTLAND, Ore., June 10, 2025 /PRNewswire/ -- ZoomCare, a network of neighborhood clinics serving a wide variety of healthcare needs, today announced the opening of a new clinic to serve the community of Happy Valley. The new clinic is located at 17155 SE Sunnyside Road, Suite #160 in the Happy Valley Crossroads Shopping Center. The clinic will be open seven days a week. Staffed with board-certified providers who cater to a broad range of illnesses and injuries, the Happy Valley clinic will also include preventive care services. The location features five exam rooms and offers on-site labs and prescriptions, allowing patients to leave with medications in hand. Since 2006, ZoomCare has been known for its patient experience, which is focused on compassion, quality, and efficiency. "ZoomCare believes you shouldn't have to travel far to receive excellent care," said Jeff Fee, Chief Executive Officer of ZoomCare. "We are thrilled to join the Happy Valley community. Opening this new location aligns perfectly with our mission to make healthcare easy and accessible for everyone." The company will celebrate the new clinic opening with an Open House event on Friday, Jun. 13, from 11 a.m. - 2 p.m. The Open House is open to the public and will offer free specialty coffee drinks and Italian sodas, fun giveaways, and a chance to meet the provider team and see the new clinic space. "This Open House is an excellent opportunity for our providers and clinic staff to get to know the people of Happy Valley," said Jennifer Alemany, Director of Clinical Operations in Portland. "We hope folks will come by, meet our team, and learn more about how ZoomCare can help with their healthcare needs now and in the future!" ZoomCare accepts Medicare and Medicare Advantage at all of its 47 locations in Oregon and Washington. Using Medicare-certified software platform Athenahealth, ZoomCare can access and share electronic health records with other providers and health systems. This certified software platform also lets ZoomCare establish partnerships with large health systems and insurance plans to increase patient access to primary, urgent, emergency, and specialty care. About ZoomCareZoomCare's vision is to make healthcare easy. Founded in 2006 in Portland, Oregon, ZoomCare operates more than 47 urgent, primary, emergency care, and specialty locations throughout Oregon and Washington. With conveniently located neighborhood clinics, plus evening and weekend hours, ZoomCare is committed to providing better access to healthcare and delivering evidence-based care with kindness at every visit. For more information, visit Follow ZoomCare on Facebook, Instagram, LinkedIn, and X. Media ContactAmanda Gibbs Director of Communications agibbs@ View original content to download multimedia: SOURCE ZoomCare

Backing the Future of Global Biotech: Reynold Lemkins' Strategy Across Borders and Stages
Backing the Future of Global Biotech: Reynold Lemkins' Strategy Across Borders and Stages

Business Wire

timean hour ago

  • Business Wire

Backing the Future of Global Biotech: Reynold Lemkins' Strategy Across Borders and Stages

HONG KONG--(BUSINESS WIRE)-- Reynold Lemkins Group, an international investment firm focused on value-driven cross-border capital deployment, announced the continued advancement of its strategic focus in late-stage healthcare, AI-powered therapeutics, and Asia-centered biotech commercialization. Bridging East and West in biotech investing, Reynold Lemkins backs science-driven companies with cross-border capital and global scale strategies. Share As part of this strategy, Reynold Lemkins recently participated in the IPO of VISEN Pharmaceuticals on the Hong Kong Stock Exchange (HKEX: 02561). VISEN, a biopharmaceutical company specializing in long-acting growth hormone therapies, attracted strong institutional demand and represents the kind of regulatory-validated, commercially scalable business the firm targets. Reynold Lemkins invested alongside globally recognized healthcare investors including HongShan Capital Group (previously Sequoia China), Sofinnova, Vivo Capital, OrbiMed, and WuXi Biologics (HKEX: 2269), reinforcing its commitment to cross-border innovation and long-term capital alignment. This investment underscores Reynold Lemkins' broader strategy of supporting science-driven, late-stage companies with scalable market potential—particularly those operating at the convergence of AI, therapeutics, and Asia-Pacific commercialization. 'Our approach focuses on more than capital—we provide strategic insight and cross-border connectivity to help companies scale,' said Kris Haoran Liu, President and Chief Investment Officer at Reynold Lemkins Group. 'Biotech firms entering public markets need partners who understand both the science and the structure of global growth.' With Asia playing an increasingly pivotal role in global healthcare, Reynold Lemkins sees a growing need for capital strategies that link scientific innovation with scalable regional execution. At the same time, the firm closely tracks trends in the U.S. and other mature markets, where biotech companies are navigating longer paths to liquidity and require strategic partners with global reach. Reynold Lemkins positions itself at this intersection—bridging East and West, public and private markets—to support companies shaping the next era of patient-centered care. To learn more, visit follow us on LinkedIn, or explore our insights on Medium.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store